<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37104709</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1929-0748</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>31</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>Characterizing Symptoms and Identifying Biomarkers of Long COVID in People With and Without HIV: Protocol for a Remotely Conducted Prospective Observational Cohort Study.</ArticleTitle><Pagination><StartPage>e47079</StartPage><MedlinePgn>e47079</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e47079</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/47079</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Living with HIV is a risk factor for severe acute COVID-19, but it is unknown whether it is a risk factor for long COVID.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aims to characterize symptoms, sequelae, and cognition formally and prospectively 12 months following SARS-CoV-2 infection in people living with HIV compared with people without HIV. People with no history of SARS-CoV-2 infection, both with and without HIV, are enrolled as controls. The study also aims to identify blood-based biomarkers or patterns of immune dysregulation associated with long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective observational cohort study enrolled participants into 1 of the following 4 study arms: people living with HIV who had SARS-CoV-2 infection for the first time &lt;4 weeks before enrollment (HIV+COVID+ arm), people without HIV who had SARS-CoV-2 infection for the first time within 4 weeks of enrollment (HIV-COVID+ arm), people living with HIV who believed they never had SARS-CoV-2 infection (HIV+COVID- arm), and people without HIV who believed they never had SARS-CoV-2 infection (HIV-COVID- arm). At enrollment, participants in the COVID+ arms recalled their symptoms, mental health status, and quality of life in the month before having SARS-CoV-2 infection via a comprehensive survey administered by telephone or on the web. All participants completed the same comprehensive survey 1, 2, 4, 6, and 12 months after post-acute COVID-19 symptom onset or diagnosis, if asymptomatic, (COVID+ arms) or after enrollment (COVID- arms) on the web or by telephone. In total, 11 cognitive assessments were administered by telephone at 1 and 4 months after symptom onset (COVID+ arms) or after enrollment (COVID- arms). A mobile phlebotomist met the participants at a location of their choice for height and weight measurements, orthostatic vital signs, and a blood draw. Participants in the COVID+ arms donated blood 1 and 4 months after COVID-19, and participants in the COVID- arms donated blood once or none. Blood was then shipped overnight to the receiving study laboratory, processed, and stored.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This project was funded in early 2021, and recruitment began in June 2021. Data analyses will be completed by summer 2023. As of February 2023, a total of 387 participants were enrolled in this study, with 345 participants having completed enrollment or baseline surveys together with at least one other completed study event. The 345 participants includes 76 (22%) HIV+COVID+, 121 (35.1%) HIV-COVID+, 78 (22.6%) HIV+COVID-, and 70 (20.3%) HIV-COVID- participants.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study will provide longitudinal data to characterize COVID-19 recovery over 12 months in people living with and without HIV. Additionally, this study will determine whether biomarkers or patterns of immune dsyregulation associate with decreased cognitive function or symptoms of long COVID.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/47079.</AbstractText><CopyrightInformation>&#xa9;Nuria Gallego M&#xe1;rquez, Armaan Jamal, Rowena Johnston, E India Richter, Pamina M Gorbach, Tracy D Vannorsdall, Leah H Rubin, Cheryl Jennings, Alan L Landay, Michael J Peluso, Annukka A R Antar. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 31.05.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>M&#xe1;rquez</LastName><ForeName>Nuria Gallego</ForeName><Initials>NG</Initials><Identifier Source="ORCID">0000-0002-0459-8738</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jamal</LastName><ForeName>Armaan</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9540-5179</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Rowena</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5027-737X</Identifier><AffiliationInfo><Affiliation>amfAR, The Foundation for AIDS Research, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>E India</ForeName><Initials>EI</Initials><Identifier Source="ORCID">0000-0002-1717-4088</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorbach</LastName><ForeName>Pamina M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0003-2100-7765</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vannorsdall</LastName><ForeName>Tracy D</ForeName><Initials>TD</Initials><Identifier Source="ORCID">0000-0003-3103-1371</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubin</LastName><ForeName>Leah H</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0003-2749-6328</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jennings</LastName><ForeName>Cheryl</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0002-3508-5350</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Rush University Medical College, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landay</LastName><ForeName>Alan L</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0001-9645-1356</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Rush University Medical College, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peluso</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-0585-6230</Identifier><AffiliationInfo><Affiliation>Division of HIV, Infectious Diseases, and Global Medicine, University of California, California, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antar</LastName><ForeName>Annukka A R</ForeName><Initials>AAR</Initials><Identifier Source="ORCID">0000-0002-6775-1103</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 AI143391</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI157875</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AI147159</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AI094189</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">HIV</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">postacute sequelae of SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">post&#x2013;acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">prospective observational cohort study</Keyword><Keyword MajorTopicYN="N">remote participation</Keyword><Keyword MajorTopicYN="N">remote study</Keyword></KeywordList><CoiStatement>Conflicts of Interest: Under a private license agreement, TDV is entitled to a share of royalty from the sales of the products described in this study. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict-of-interest policies. No other authors declare a conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>27</Day><Hour>15</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37104709</ArticleId><ArticleId IdType="pmc">PMC10234419</ArticleId><ArticleId IdType="doi">10.2196/47079</ArticleId><ArticleId IdType="pii">v12i1e47079</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. World Health Organization.  [2023-03-07].  
 https://covid19.who.int
.</Citation></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Social Sci Med. 2021 Jan;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Post-COVID Conditions. Centers for Disease Control and Prevention.  [2023-02-17].  
 https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
.</Citation></Reference><Reference><Citation>Coronavirus disease (COVID-19): post COVID-19 condition. World Health Organization. 2023.  [2023-02-17].  
 https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition
.</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, Redfield S, Austin JP, Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021 Aug;38:101019. doi: 10.1016/j.eclinm.2021.101019. 
 
S2589-5370(21)00299-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SK, olde Hartman TC, Rosmalen JG. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022 Aug;400(10350):452&#x2013;61. doi: 10.1016/s0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Kr&#xe4;usslich H-G, Brockmann SO, G&#xf6;pel S, Kindle G, Merle U, Steinacker JM, Rothenbacher D, Kern WV, EPILOC Phase 1 Study Group  Post-acute sequelae of covid-19 six to 12 months after infection: population based study. BMJ. 2022 Oct 13;379:e071050. doi: 10.1136/bmj-2022-071050. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071050</ArticleId><ArticleId IdType="pmc">PMC9557001</ArticleId><ArticleId IdType="pubmed">36229057</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021 May 03;4(5):e2111417. doi: 10.1001/jamanetworkopen.2021.11417. 
 
2780376</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021 Sep 28;18(9):e1003773. doi: 10.1371/journal.pmed.1003773. 
 
PMEDICINE-D-21-02226</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, Basson MD, Bennett TD, Bergquist T, Boudreau EA, Bramante CT, Byrd JB, Callahan TJ, Chan LE, Chu H, Chute CG, Coleman BD, Davis HE, Gagnier J, Greene CS, Hillegass WB, Kavuluru R, Kimble WD, Koraishy FM, K&#xf6;hler S, Liang C, Liu F, Liu H, Madhira V, Madlock-Brown CR, Matentzoglu N, Mazzotti DR, McMurry JA, McNair DS, Moffitt RA, Monteith TS, Parker AM, Perry MA, Pfaff E, Reese JT, Saltz J, Schuff RA, Solomonides AE, Solway J, Spratt H, Stein GS, Sule AA, Topaloglu U, Vavougios GD, Wang L, Haendel MA, Robinson PN. Characterizing long COVID: deep phenotype of a complex condition. EBioMedicine. 2021 Dec;74:103722. doi: 10.1016/j.ebiom.2021.103722. 
 
S2352-3964(21)00516-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando H, Bennett T, Byrd J. Challenges in defining long COVID: striking differences across literature, electronic health records, and patient-reported information. MedRxiv. 2021:1733. doi: 10.1101/2021.03.20.21253896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021 Jun 22;594(7862):259&#x2013;64. doi: 10.1038/s41586-021-03553-9.10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection. World Health Organization.  [2023-05-16].  
 https://www.who.int/publications-detail-redirect/WHO-2019-nCoV-Clinical-HIV-2021.1
.</Citation></Reference><Reference><Citation>Johnston R. The first 6 months of HIV-SARS-CoV-2 coinfection: outcomes for 6947 individuals. Curr Opin HIV AIDS. 2021 Jan;16(1):54&#x2013;62. doi: 10.1097/COH.0000000000000654.01222929-202101000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COH.0000000000000654</ArticleId><ArticleId IdType="pubmed">33165007</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Sun J, Patel RC, Zhang J, Guo S, Zheng Q, Olex AL, Olatosi B, Weissman SB, Islam JY, Chute CG, Haendel M, Kirk GD, Li X, Moffitt R, Akelsrod H, Crandall KA, Francheschini N, French E, Po-Yu Chiang T, Caleb-Alexander G, Andersen KM, Vinson AJ, Brown TT, Mannon RB. Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data. Lancet HIV. 2021 Nov;8(11):e690&#x2013;700. doi: 10.1016/s2352-3018(21)00239-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-3018(21)00239-3</ArticleId><ArticleId IdType="pmc">PMC8514200</ArticleId><ArticleId IdType="pubmed">34655550</ArticleId></ArticleIdList></Reference><Reference><Citation>Dandachi D, Geiger G, Montgomery M. Characteristics, comorbidities, and outcomes in a multicenter registry of patients with human immunodeficiency virus and coronavirus disease 2019. Clin Infect Dis. 2021;73(7):e1964&#x2013;72. doi: 10.1093/cid/ciaa1339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1339</ArticleId><ArticleId IdType="pmc">PMC7499544</ArticleId><ArticleId IdType="pubmed">32905581</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro A, Bender IR, Whitney B. Factors associated with severity of COVID-19 disease in a multicenter cohort of people with HIV in the United States, March-December 2020. J Acquired Immune Deficiency Syndromes. 2022;90(4):4600. doi: 10.1097/qai.0000000000002989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/qai.0000000000002989</ArticleId><ArticleId IdType="pmc">PMC9246864</ArticleId><ArticleId IdType="pubmed">35364600</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023 Mar 13;21(3):133&#x2013;46. doi: 10.1038/s41579-022-00846-2. 
 
10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest. 2022 Aug 01;132(15):e161167. doi: 10.1172/JCI161167. doi: 10.1172/JCI161167.161167</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Klatt NR, Chomont N, Douek DC, Deeks SG. Immune activation and HIV persistence: implications for curative approaches to HIV infection. Immunol Rev. 2013 Jul 16;254(1):326&#x2013;42. doi: 10.1111/imr.12065. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12065</ArticleId><ArticleId IdType="pmc">PMC3694608</ArticleId><ArticleId IdType="pubmed">23772629</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CM, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, Kelleher AD, Matthews GV. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022 Feb 13;23(2):210&#x2013;6. doi: 10.1038/s41590-021-01113-x.10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard S, Epsi N, Pollett S. Performance of the inFLUenza patient-reported outcome plus (FLU-PRO Plus) instrument in patients with coronavirus disease 2019. Open Forum Infect Dis. 2021;8(12):1&#x2013;8. doi: 10.1093/ofid/ofab517PubMed:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab517PubMed:</ArticleId><ArticleId IdType="pmc">PMC8661080</ArticleId><ArticleId IdType="pubmed">34901299</ArticleId></ArticleIdList></Reference><Reference><Citation>Munari AB, Gulart AA, Dos Santos K, Ven&#xe2;ncio RS, Karloh M, Mayer AF. Modified medical research council dyspnea scale in GOLD classification better reflects physical activities of daily living. Respir Care. 2018 Jan 05;63(1):77&#x2013;85. doi: 10.4187/respcare.05636. 
 
respcare.05636</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.05636</ArticleId><ArticleId IdType="pubmed">28874609</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarroll ML, Pohle-Krauza RJ, Volsko TA, Martin JL, Krauza ML. Use of the breathlessness, cough, and sputum scale (BCSS(&#xa9;)) in pulmonary rehabilitation. Open Respir Med J. 2013;7:1&#x2013;5. doi: 10.2174/1874306401307010001. 
 
TORMJ-7-1</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874306401307010001</ArticleId><ArticleId IdType="pmc">PMC3594703</ArticleId><ArticleId IdType="pubmed">23494521</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastien C, Valli&#xe8;res A, Morin C. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):8246&#x2013;307. doi: 10.1016/s1389-9457(00)00065-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1389-9457(00)00065-4</ArticleId><ArticleId IdType="pubmed">11438246</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin C, Belleville G, B&#xe9;langer L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601&#x2013;8. doi: 10.1093/sleep/34.5.601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/34.5.601</ArticleId><ArticleId IdType="pmc">PMC3079939</ArticleId><ArticleId IdType="pubmed">21532953</ArticleId></ArticleIdList></Reference><Reference><Citation>Valko P, Bassetti C, Bloch K, Held U, Baumann C. Validation of the fatigue severity scale in a Swiss cohort. Sleep. 2008 Nov;31(11):1601&#x2013;7. doi: 10.1093/sleep/31.11.1601. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/31.11.1601</ArticleId><ArticleId IdType="pmc">PMC2579971</ArticleId><ArticleId IdType="pubmed">19014080</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606&#x2013;13. doi: 10.1046/j.1525-1497.2001.016009606.x. 
 
jgi01114</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009 Apr;114(1-3):163&#x2013;73. doi: 10.1016/j.jad.2008.06.026.S0165-0327(08)00282-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2008.06.026</ArticleId><ArticleId IdType="pubmed">18752852</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer R, Kroenke K, Williams J, L&#xf6;we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092&#x2013;7. doi: 10.1001/archinte.166.10.1092. 
 
166/10/1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons RD, Weiss DJ, Pilkonis PA, Frank E, Moore T, Kim JB, Kupfer DJ. Development of a computerized adaptive test for depression. Arch Gen Psychiatry. 2012 Nov 01;69(11):1104&#x2013;12. doi: 10.1001/archgenpsychiatry.2012.14. 
 
1387857</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archgenpsychiatry.2012.14</ArticleId><ArticleId IdType="pmc">PMC3551289</ArticleId><ArticleId IdType="pubmed">23117634</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons RD, Hooker G, Finkelman MD, Weiss DJ, Pilkonis PA, Frank E, Moore T, Kupfer DJ. The computerized adaptive diagnostic test for major depressive disorder (CAD-MDD): a screening tool for depression. J Clin Psychiatry. 2013 Jul;74(7):669&#x2013;74. doi: 10.4088/JCP.12m08338. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.12m08338</ArticleId><ArticleId IdType="pmc">PMC3977175</ArticleId><ArticleId IdType="pubmed">23945443</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbons RD, Weiss DJ, Pilkonis PA, Frank E, Moore T, Kim JB, Kupfer DJ. Development of the CAT-ANX: a computerized adaptive test for anxiety. Am J Psychiatry. 2014 Feb;171(2):187&#x2013;94. doi: 10.1176/appi.ajp.2013.13020178. 
 
1725889</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2013.13020178</ArticleId><ArticleId IdType="pmc">PMC4052830</ArticleId><ArticleId IdType="pubmed">23929270</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, Huppert FA. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc. 2002 Mar;50(3):530&#x2013;4. doi: 10.1046/j.1532-5415.2002.50122.x.50122</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1532-5415.2002.50122.x</ArticleId><ArticleId IdType="pubmed">11943052</ArticleId></ArticleIdList></Reference><Reference><Citation>McHorney C A, Ware J E, Raczek A E. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993 Mar;31(3):247&#x2013;63. doi: 10.1097/00005650-199303000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199303000-00006</ArticleId><ArticleId IdType="pubmed">8450681</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Sherbourne CD. The MOS 36-ltem Short-Form Health Survey (SF-36) Medical Care. 1992;30(6):473&#x2013;83. doi: 10.1097/00005650-199206000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) Qual Life Res. 2011 Dec 9;20(10):1727&#x2013;36. doi: 10.1007/s11136-011-9903-x. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008 Sep;15(3):194&#x2013;200. doi: 10.1080/10705500802222972.901471909</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10705500802222972</ArticleId><ArticleId IdType="pubmed">18696313</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt J, Benedict R. Hopkins Verbal Learning Test&#x2013;Revised&#x2122;. Lutz, FL: Psychological Assessment Resources; 2001.</Citation></Reference><Reference><Citation>Arango-Lasprilla J, Rivera D, Garza M, Saracho C, Rodr&#xed;guez W, Rodr&#xed;guez-Agudelo Y, Aguayo A, Schebela S, Luna M, Longoni M, Mart&#xed;nez C, Doyle S, Ocampo-Barba N, Galarza-del-Angel J, Aliaga A, Bringas M, Esenarro L, Garc&#xed;a-Egan P, Perrin P. Hopkins verbal learning test&#x2013; revised: normative data for the Latin American Spanish speaking adult population. NeuroRehabilitation. 2015 Nov 26;37(4):699&#x2013;718. doi: 10.3233/nre-151286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/nre-151286</ArticleId><ArticleId IdType="pubmed">26639933</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrazik M, Millis S, Drane DL. The oral trail making test: effects of age and concurrent validity. Arch Clin Neuropsychol. 2010 May 02;25(3):236&#x2013;43. doi: 10.1093/arclin/acq006. 
 
acq006</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acq006</ArticleId><ArticleId IdType="pmc">PMC2858599</ArticleId><ArticleId IdType="pubmed">20197294</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler D. Escala de Memoria de Wechsler-IV: Manual de correcci&#xf3;n y aplicaci&#xf3;n. New York, NY: Pearson; 2008.</Citation></Reference><Reference><Citation>Wechsler D. WAIS-IV: Administration and Scoring Manual. San Antonio, TX: Psychological Corporation; 2008.</Citation></Reference><Reference><Citation>Wechsler D, Meng Y. WAIS-IV, Escala de inteligencia de Wechsler para adultos-IV. Mexico City, Mexico: Manual Moderno; 2014.</Citation></Reference><Reference><Citation>Schretlen D, Vannorsdall T. Calibrated Ideational Fluency Assessment (CIFA) professional manual. Odessa, FL: Psychological Assessment Resources; 2010.</Citation></Reference><Reference><Citation>Olabarrieta-Landa L, Rivera D, Galarza-del-Angel J, Garza M, Saracho C, Rodr&#xed;guez W, Ch&#xe1;vez-Oliveros M, R&#xe1;bago B, Leibach G, Schebela S, Mart&#xed;nez C, Luna M, Longoni M, Ocampo-Barba N, Rodr&#xed;guez G, Aliaga A, Esenarro L, Garc&#xed;a de la Cadena C, Perrin B, Arango-Lasprilla J. Verbal fluency tests: normative data for the Latin American Spanish speaking adult population. NeuroRehabilitation. 2015 Apr 25;37(4):515&#x2013;61. doi: 10.3233/nre-151279.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/nre-151279</ArticleId><ArticleId IdType="pubmed">26639930</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan JE, Sherman E, Hrabok M. A Compendium of Neuropsychological Tests Administration, Tests, Norms, and Commentary. Oxford, United Kingdom: Oxford University Press; 1991.</Citation></Reference><Reference><Citation>Lezak M. Neuropsychological assessment. Oxford ; New York: Oxford University Press; 2012.</Citation></Reference><Reference><Citation>Lacritz L, Carlew A, Livingstone J, Bailey K, Parker A, Diaz A. Patient satisfaction with telephone neuropsychological assessment. Arch Clin Neuropsychol. 2020;35(8):1240&#x2013;8. doi: 10.1093/arclin/acaa097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acaa097</ArticleId><ArticleId IdType="pmc">PMC7665292</ArticleId><ArticleId IdType="pubmed">33124648</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanho TC, Amorim L, Zihl J, Palha JA, Sousa N, Santos NC. Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments. Front Aging Neurosci. 2014;6:16. doi: 10.3389/fnagi.2014.00016. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00016</ArticleId><ArticleId IdType="pmc">PMC3933813</ArticleId><ArticleId IdType="pubmed">24611046</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlew A, Fatima H, Livingstone J, Reese C, Lacritz L, Pendergrass C, Bailey KC, Presley C, Mokhtari B, Cullum CM. Cognitive assessment via telephone: a scoping review of instruments. Arch Clin Neuropsychol. 2020 Nov 19;35(8):1215&#x2013;33. doi: 10.1093/arclin/acaa096. 
 
5939750</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acaa096</ArticleId><ArticleId IdType="pmc">PMC7665291</ArticleId><ArticleId IdType="pubmed">33106856</ArticleId></ArticleIdList></Reference><Reference><Citation>Matchanova A, Babicz M, Medina L. Latent structure of a brief clinical battery of neuropsychological tests administered in-home via telephone. Arch Clin Neuropsychol. 2021;36(6):6037&#x2013;886. doi: 10.1093/arclin/acaa111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acaa111</ArticleId><ArticleId IdType="pubmed">33236037</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S, Besser L, Dodge HH, Teylan M, Ferris S, Goldstein FC, Giordani B, Kramer J, Loewenstein D, Marson D, Mungas D, Salmon D, Welsh-Bohmer K, Zhou X-H, Shirk SD, Atri A, Kukull WA, Phelps C, Morris JC. Version 3 of the alzheimer disease centers' neuropsychological test battery in the uniform data set (UDS) Alzheimer Dis Assoc Disord. 2018;32(1):10&#x2013;7. doi: 10.1097/WAD.0000000000000223. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000223</ArticleId><ArticleId IdType="pmc">PMC5821520</ArticleId><ArticleId IdType="pubmed">29240561</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannorsdall TD, Brigham E, Fawzy A, Raju S, Gorgone A, Pletnikova A, Lyketsos CG, Parker AM, Oh ES. Cognitive dysfunction, psychiatric distress, and functional decline after COVID-19. J Acad Consult Liaison Psychiatry. 2022 Mar;63(2):133&#x2013;43. doi: 10.1016/j.jaclp.2021.10.006. 
 
S2667-2960(21)00185-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaclp.2021.10.006</ArticleId><ArticleId IdType="pmc">PMC8591857</ArticleId><ArticleId IdType="pubmed">34793996</ArticleId></ArticleIdList></Reference><Reference><Citation>LDMS software homepage. LDMS Software.  [2023-02-17].  
 https://www.ldms.org/products/
</Citation></Reference><Reference><Citation>Klein J, Wood J, Jaycox J. Distinguishing features of Long COVID identified through immune profiling. MedRxiv. 2022:2667. doi: 10.1101/2022.08.09.22278592PubMed:.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592PubMed:</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes S, Bosurgi L, Dutzmann J, Sedding D, Frese T, Girndt M, H&#xf6;ll JI, Gekle M, Mikolajczyk R, Binder M. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022 Jun 21;3(6):100663. doi: 10.1016/j.xcrm.2022.100663. 
 
S2666-3791(22)00195-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, Xie J, Kornilov SA, Scherler K, Pavlovitch-Bedzyk AJ, Dong S, Lausted C, Lee I, Fallen S, Dai CL, Baloni P, Smith B, Duvvuri VR, Anderson KG, Li J, Yang F, Duncombe CJ, McCulloch DJ, Rostomily C, Troisch P, Zhou J, Mackay S, DeGottardi Q, May DH, Taniguchi R, Gittelman RM, Klinger M, Snyder TM, Roper R, Wojciechowska G, Murray K, Edmark R, Evans S, Jones L, Zhou Y, Rowen L, Liu R, Chour W, Algren HA, Berrington WR, Wallick JA, Cochran RA, Micikas ME, ISB-Swedish COVID-19 Biobanking Unit. Wrin T, Petropoulos CJ, Cole HR, Fischer TD, Wei W, Hoon DS, Price ND, Subramanian N, Hill JA, Hadlock J, Magis AT, Ribas A, Lanier LL, Boyd SD, Bluestone JA, Chu H, Hood L, Gottardo R, Greenberg PD, Davis MM, Goldman JD, Heath JR. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022 Mar 03;185(5):881&#x2013;95.e20. doi: 10.1016/j.cell.2022.01.014. 
 
S0092-8674(22)00072-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M, Lu S, Tang A. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021;224(11):1839&#x2013;48. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN, REDCap Consortium  The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. 
 
S1532-0464(19)30126-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>36-item short form survey (SF-36) scoring instructions. RAND Corporation.  [2023-02-17].  
 https://www.rand.org/health-care/surveys_tools/mos/36-item-short-form/scoring.html
.</Citation></Reference><Reference><Citation>Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item health survey 1.0. Health Econ. 1993 Oct;2(3):217&#x2013;27. doi: 10.1002/hec.4730020305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.4730020305</ArticleId><ArticleId IdType="pubmed">8275167</ArticleId></ArticleIdList></Reference><Reference><Citation>Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC. HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol. 2016 Apr;12(4):234&#x2013;48. doi: 10.1038/nrneurol.2016.27. 
 
nrneurol.2016.27</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.27</ArticleId><ArticleId IdType="pmc">PMC4937456</ArticleId><ArticleId IdType="pubmed">26965674</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, Walt DR. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023 Feb 08;76(3):e487&#x2013;90. doi: 10.1093/cid/ciac722. 
 
6686531</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021 Jun 23;12:698169. doi: 10.3389/fmicb.2021.698169. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S, Kril I, Nadizhko O, Matsyura O, Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int. 2022 Sep 01;42(9):1523&#x2013;30. doi: 10.1007/s00296-022-05146-9. 
 
10.1007/s00296-022-05146-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, Chan V, Ling L, Joynt G, Hui DS, Chow KM, Ng SS, Li TC, Ng RW, Yip TC, Wong GL, Chan FK, Wong CK, Chan PK, Ng SC. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021 Apr 11;70(4):698&#x2013;706. doi: 10.1136/gutjnl-2020-323020. 
 
gutjnl-2020-323020</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, F&#xfc;rst J, Schulze-Rothe S, Wallukat A, H&#xf6;nicke A-S, M&#xfc;ller J. Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100. 
 
S2589-9090(21)00020-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, Hanitsch L, Wittke K, Bauer S, Konietschke F, Paul F, Bellmann-Strobl J, Kedor C, Scheibenbogen C, Sotzny F. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J Transl Med. 2022 Mar 22;20(1):138. doi: 10.1186/s12967-022-03346-2. 
 
10.1186/s12967-022-03346-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022 Jan 21;375(6578):267&#x2013;9. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M, Deveau T, Munter S. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023;133(3):4631. doi: 10.1172/jci163669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar B, Boustani K, Ogger PP, Papadaki A, Tonkin J, Orton CM, Ghai P, Suveizdyte K, Hewitt RJ, Desai SR, Devaraj A, Snelgrove RJ, Molyneaux PL, Garner JL, Peters JE, Shah PL, Lloyd CM, Harker JA. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity. 2022 Mar 08;55(3):542&#x2013;56.e5. doi: 10.1016/j.immuni.2022.01.017. 
 
S1074-7613(22)00046-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.01.017</ArticleId><ArticleId IdType="pmc">PMC8789571</ArticleId><ArticleId IdType="pubmed">35151371</ArticleId></ArticleIdList></Reference><Reference><Citation>Yendewa G, Perez JA, Patil N, McComsey GA. HIV infection is associated with higher risk of post-acute sequelae of SARS-CoV-2 (PASC) however vaccination is protective. SSRN J. 2022 Nov 15; doi: 10.2139/ssrn.4276609. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4276609</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, Blumberg L, Mayet N, Tempia S, Parker A, Nel J, Perumal R, Groome MJ, Conradie F, Ndjeka N, Sigfrid L, Merson L, Cohen C. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023 Mar;128:102&#x2013;11. doi: 10.1016/j.ijid.2022.12.036. 
 
S1201-9712(22)00676-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.12.036</ArticleId><ArticleId IdType="pmc">PMC9800016</ArticleId><ArticleId IdType="pubmed">36587841</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>